STCube

STCube Total Assets

The Total Assets of STCube (052020.KQ) as of Oct 24, 2026 is 90.23 B KRW. In the previous year, Total Assets was 111.90 B KRW — a change of -19.37% (lower).

Total Assets

90.23 BKRW

YoY

-19.37%

Last updated:

Total Assets of STCube is 2025 90.23 B KRW. Total Assets of STCube was 2024 111.90 B KRW. It decreases by -19.37% lower compared to the previous year.

The STCube Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2018
58.62 B KRW
Jan 1, 2019
52.38 B KRW
Jan 1, 2020
50.45 B KRW
Jan 1, 2021
25.86 B KRW
Jan 1, 2022
61.07 B KRW
Jan 1, 2023
45.96 B KRW
Jan 1, 2024
111.90 B KRW
Jan 1, 2025
90.23 B KRW
The STCube Total Assets history
YEARTotal AssetsYoY
90.23 BKRW-19.37%
111.90 BKRW+143.50%
45.96 BKRW-24.75%
61.07 BKRW+136.15%
25.86 BKRW-48.74%
50.45 BKRW-3.67%
52.38 BKRW-10.64%
58.62 BKRW+121.55%
26.46 BKRW-35.11%
40.77 BKRW+74.51%
23.36 BKRW-25.03%
31.17 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

STCube Stock analysis

What does STCube do? STCube Inc. generates revenue through its two business segments. The IT segment distributes CCTV lenses and related components, targeting businesses requiring security solutions. The BT segment develops and licenses immunomodulatory anticancer drug therapeutic candidates, selling to pharmaceutical companies and research institutions. Both segments operate under the company's brand, leveraging its IT and biotechnology expertise. The IT segment focuses on closed-circuit television lens distribution, serving commercial and industrial clients seeking reliable security infrastructure. The BT segment's drug development and licensing activities cater to the pharmaceutical industry, providing innovative therapeutic candidates for cancer treatment. These offerings align with STCube's dual expertise in technology and biotechnology. STCube's revenue streams are derived from product distribution in the IT sector and licensing agreements in the biotechnology sector. The company's clients include businesses needing CCTV components and pharmaceutical firms interested in anticancer drug development. This dual approach allows STCube to serve distinct market segments with specialized solutions. STCube is one of the most popular companies on Eulerpool.

Frequently Asked Questions about STCube stock

Total Assets of STCube is 90.23 B KRW in 2025.

Total Assets of STCube changed from 111.90 B KRW to 90.23 B KRW, representing a -19.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets STCube since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's STCube historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — STCube

All Key Metrics — STCube